Beisol Pharma Lubbeek

Lubbeek ·KBO/BCE: BE 0773.648.838

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	8.2%	23.6%	better than 33% of 1401 sector peers
Net result	€625	€8k	better than 33% of 1398 sector peers
Equity	€9k	€26k	better than 35% of 1402 sector peers
Gross operating margin	€19k	€35k	better than 36% of 1395 sector peers
Total assets	€109k	€133k	better than 45% of 1402 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€109k
Fixed assets	21/28	€109k
Intangible fixed assets	21	€109k
Current assets	29/58	€441
Amounts receivable within one year	40/41	€397
Cash & bank	54/58	€44
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€109k
Equity	10/15	€9k
Contributions / capital	10/11	€5k
Reserves	13	€4k
Amounts payable	17/49	€100k
Amounts payable within one year	42/48	€100k
Trade debts payable within one year	44	€11k
Income statement
Turnover	70	€30k
Gross operating margin	9900	€19k
Operating result	9901	€2k
Financial charges	65	€275
Result before taxes	9903	€2k
Income taxes	67/77	€1k
Net result for the period	9904	€625
Result to be appropriated	9905	€625

Summary